Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Hepatic Impairment
Clinical trial NCT04145596 · COMPLETED
Trial details
- NCT number
- NCT04145596
- Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-14
- Primary completion
- 2020-04-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.